Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 284

1.

Genetic variation in the vitamin d pathway in relation to risk of prostate cancer--results from the breast and prostate cancer cohort consortium.

Mondul AM, Shui IM, Yu K, Travis RC, Stevens VL, Campa D, Schumacher FR, Ziegler RG, Bueno-de-Mesquita HB, Berndt S, Crawford ED, Gapstur SM, Gaziano JM, Giovannucci E, Haiman CA, Henderson BE, Hunter DJ, Johansson M, Key TJ, Le Marchand L, Lindström S, McCullough ML, Navarro C, Overvad K, Palli D, Purdue M, Stampfer MJ, Weinstein SJ, Willett WC, Yeager M, Chanock SJ, Trichopoulos D, Kolonel LN, Kraft P, Albanes D.

Cancer Epidemiol Biomarkers Prev. 2013 Apr;22(4):688-96. doi: 10.1158/1055-9965.EPI-13-0007-T. Epub 2013 Feb 1.

2.

Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk.

Ahn J, Albanes D, Berndt SI, Peters U, Chatterjee N, Freedman ND, Abnet CC, Huang WY, Kibel AS, Crawford ED, Weinstein SJ, Chanock SJ, Schatzkin A, Hayes RB; Prostate, Lung, Colorectal and Ovarian Trial Project Team.

Carcinogenesis. 2009 May;30(5):769-76. doi: 10.1093/carcin/bgp055. Epub 2009 Mar 2.

3.

Inherited variation in vitamin D genes is associated with predisposition to autoimmune disease type 1 diabetes.

Cooper JD, Smyth DJ, Walker NM, Stevens H, Burren OS, Wallace C, Greissl C, Ramos-Lopez E, Hyppönen E, Dunger DB, Spector TD, Ouwehand WH, Wang TJ, Badenhoop K, Todd JA.

Diabetes. 2011 May;60(5):1624-31. doi: 10.2337/db10-1656. Epub 2011 Mar 25.

4.

Genetic Polymorphisms in Vitamin D Metabolism and Signaling Genes and Risk of Breast Cancer: A Nested Case-Control Study.

Clendenen TV, Ge W, Koenig KL, Axelsson T, Liu M, Afanasyeva Y, Andersson A, Arslan AA, Chen Y, Hallmans G, Lenner P, Kirchhoff T, Lundin E, Shore RE, Sund M, Zeleniuch-Jacquotte A.

PLoS One. 2015 Oct 21;10(10):e0140478. doi: 10.1371/journal.pone.0140478. eCollection 2015.

5.

Response to Antenatal Cholecalciferol Supplementation Is Associated With Common Vitamin D-Related Genetic Variants.

Moon RJ, Harvey NC, Cooper C, D'Angelo S, Curtis EM, Crozier SR, Barton SJ, Robinson SM, Godfrey KM, Graham NJ, Holloway JW, Bishop NJ, Kennedy S, Papageorghiou AT, Schoenmakers I, Fraser R, Gandhi SV, Prentice A, Inskip HM, Javaid MK; Maternal Vitamin D Osteoporosis Study Trial Group.

J Clin Endocrinol Metab. 2017 Aug 1;102(8):2941-2949. doi: 10.1210/jc.2017-00682.

PMID:
28575224
6.

Association of common gene variants in vitamin D modulating genes and colon cancer recurrence.

Szkandera J, Absenger G, Pichler M, Stotz M, Langsenlehner T, Samonigg H, Renner W, Gerger A.

J Cancer Res Clin Oncol. 2013 Sep;139(9):1457-64. doi: 10.1007/s00432-013-1461-x. Epub 2013 Jun 23.

PMID:
23793229
7.

Circulating vitamin D, vitamin D-related genetic variation, and risk of fatal prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.

Shui IM, Mondul AM, Lindström S, Tsilidis KK, Travis RC, Gerke T, Albanes D, Mucci LA, Giovannucci E, Kraft P; Breast and Prostate Cancer Cohort Consortium Group.

Cancer. 2015 Jun 15;121(12):1949-56. doi: 10.1002/cncr.29320. Epub 2015 Mar 2.

8.

Impaired vitamin D activation and association with CYP24A1 haplotypes in differentiated thyroid carcinoma.

Penna-Martinez M, Ramos-Lopez E, Stern J, Kahles H, Hinsch N, Hansmann ML, Selkinski I, Grünwald F, Vorländer C, Bechstein WO, Zeuzem S, Holzer K, Badenhoop K.

Thyroid. 2012 Jul;22(7):709-16. doi: 10.1089/thy.2011.0330. Epub 2012 Jun 12.

9.

Exploring the genetic architecture of circulating 25-hydroxyvitamin D.

Hiraki LT, Major JM, Chen C, Cornelis MC, Hunter DJ, Rimm EB, Simon KC, Weinstein SJ, Purdue MP, Yu K, Albanes D, Kraft P.

Genet Epidemiol. 2013 Jan;37(1):92-8. doi: 10.1002/gepi.21694. Epub 2012 Nov 7.

10.

Associations of vitamin D pathway genes with circulating 25-hydroxyvitamin-D, 1,25-dihydroxyvitamin-D, and prostate cancer: a nested case-control study.

Gilbert R, Bonilla C, Metcalfe C, Lewis S, Evans DM, Fraser WD, Kemp JP, Donovan JL, Hamdy FC, Neal DE, Lane JA, Smith GD, Lathrop M, Martin RM.

Cancer Causes Control. 2015 Feb;26(2):205-218. doi: 10.1007/s10552-014-0500-5. Epub 2014 Dec 9.

11.

Vitamin D-associated genetic variation and risk of breast cancer in the breast and prostate cancer cohort consortium (BPC3).

Mondul AM, Shui IM, Yu K, Weinstein SJ, Tsilidis KK, Joshi AD, Agudo A, Berg CD, Black A, Buring JE, Chasman DI, Gaudet MM, Haiman C, Hankinson SE, Henderson BE, Hoover RN, Hunter DJ, Khaw KT, Kühn T, Kvaskoff M, Le Marchand L, Lindström S, McCullough ML, Overvad K, Peeters PH, Riboli E, Ridker PM, Stram DO, Sund M, Trichopoulos D, Tumino R, Weiderpass E, Willett W, Kraft P, Ziegler RG, Albanes D.

Cancer Epidemiol Biomarkers Prev. 2015 Mar;24(3):627-30. doi: 10.1158/1055-9965.EPI-14-1127. Epub 2014 Dec 26.

12.

Genetic variants in CYP2R1, CYP24A1, and VDR modify the efficacy of vitamin D3 supplementation for increasing serum 25-hydroxyvitamin D levels in a randomized controlled trial.

Barry EL, Rees JR, Peacock JL, Mott LA, Amos CI, Bostick RM, Figueiredo JC, Ahnen DJ, Bresalier RS, Burke CA, Baron JA.

J Clin Endocrinol Metab. 2014 Oct;99(10):E2133-7. doi: 10.1210/jc.2014-1389. Epub 2014 Jul 29.

13.

Genetic variants in vitamin d pathway genes and risk of pancreas cancer; results from a population-based case-control study in ontario, Canada.

Anderson LN, Cotterchio M, Knight JA, Borgida A, Gallinger S, Cleary SP.

PLoS One. 2013 Jun 24;8(6):e66768. doi: 10.1371/journal.pone.0066768. Print 2013.

14.

Common genetic variants in the vitamin D pathway including genome-wide associated variants are not associated with breast cancer risk among Chinese women.

Dorjgochoo T, Delahanty R, Lu W, Long J, Cai Q, Zheng Y, Gu K, Gao YT, Zheng W, Shu XO.

Cancer Epidemiol Biomarkers Prev. 2011 Oct;20(10):2313-6. doi: 10.1158/1055-9965.EPI-11-0704. Epub 2011 Aug 9.

15.

Using genetic proxies for lifecourse sun exposure to assess the causal relationship of sun exposure with circulating vitamin d and prostate cancer risk.

Bonilla C, Gilbert R, Kemp JP, Timpson NJ, Evans DM, Donovan JL, Hamdy FC, Neal DE, Fraser WD, Davey SG, Lewis SJ, Lathrop M, Martin RM.

Cancer Epidemiol Biomarkers Prev. 2013 Apr;22(4):597-606. doi: 10.1158/1055-9965.EPI-12-1248. Epub 2013 Feb 25.

16.

Single nucleotide polymorphisms in the vitamin D pathway associating with circulating concentrations of vitamin D metabolites and non-skeletal health outcomes: Review of genetic association studies.

Jolliffe DA, Walton RT, Griffiths CJ, Martineau AR.

J Steroid Biochem Mol Biol. 2016 Nov;164:18-29. doi: 10.1016/j.jsbmb.2015.12.007. Epub 2015 Dec 11. Review.

PMID:
26686945
17.

Vitamin D-related gene polymorphisms, plasma 25-hydroxyvitamin D, and breast cancer risk.

Reimers LL, Crew KD, Bradshaw PT, Santella RM, Steck SE, Sirosh I, Terry MB, Hershman DL, Shane E, Cremers S, Dworakowski E, Teitelbaum SL, Neugut AI, Gammon MD.

Cancer Causes Control. 2015 Feb;26(2):187-203. doi: 10.1007/s10552-014-0497-9. Epub 2014 Nov 25.

18.

Seasonal variation in expression of markers in the vitamin D pathway in prostate tissue.

Epstein MM, Andrén O, Kasperzyk JL, Shui IM, Penney KL, Fall K, Rider JR, Stampfer MJ, Andersson SO, Giovannucci E, Mucci LA.

Cancer Causes Control. 2012 Aug;23(8):1359-66. doi: 10.1007/s10552-012-0016-9. Epub 2012 Jun 19.

19.

Comprehensive association analysis of the vitamin D pathway genes, VDR, CYP27B1, and CYP24A1, in prostate cancer.

Holick CN, Stanford JL, Kwon EM, Ostrander EA, Nejentsev S, Peters U.

Cancer Epidemiol Biomarkers Prev. 2007 Oct;16(10):1990-9.

20.

Association of vitamin D serum levels and its common genetic determinants, with severity of liver fibrosis in genotype 1 chronic hepatitis C patients.

Petta S, Grimaudo S, Marco VD, Scazzone C, Macaluso FS, Cammà C, Cabibi D, Pipitone R, Craxì A.

J Viral Hepat. 2013 Jul;20(7):486-93. doi: 10.1111/jvh.12072. Epub 2013 Mar 25.

PMID:
23730842

Supplemental Content

Support Center